208 related articles for article (PubMed ID: 15548915)
41. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
42. Life Threatening Delayed Complication of Botulinum Toxin Injection for Treatment of Spasmodic Dysphonia.
Yershov D; Partridge R
Prague Med Rep; 2020; 121(2):114-117. PubMed ID: 32553095
[TBL] [Abstract][Full Text] [Related]
43. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
Murry T; Woodson GE
J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
[TBL] [Abstract][Full Text] [Related]
44. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
[TBL] [Abstract][Full Text] [Related]
45. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
Ludlow CL; Naunton RF; Terada S; Anderson BJ
Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
[TBL] [Abstract][Full Text] [Related]
46. [Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].
Teive HA; Scola RH; Werneck LC; Quadros Ad ; Gasparetto EL; Sá DS; Brandi IV; Macedo Filho ED
Arq Neuropsiquiatr; 2001 Mar; 59(1):97-100. PubMed ID: 11299440
[TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia.
Adler CH; Bansberg SF; Krein-Jones K; Hentz JG
Mov Disord; 2004 Sep; 19(9):1075-9. PubMed ID: 15372600
[TBL] [Abstract][Full Text] [Related]
48. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia.
Castellanos PF; Gates GA; Esselman G; Song F; Vannier MW; Kuo M
Laryngoscope; 1994 Jun; 104(6 Pt 1):656-62. PubMed ID: 8196438
[TBL] [Abstract][Full Text] [Related]
49. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
50. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
51. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
Thompson AR
J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
[TBL] [Abstract][Full Text] [Related]
52. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
Bhattacharyya N; Tarsy D
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
[TBL] [Abstract][Full Text] [Related]
53. Botulinum toxin treatment for spasmodic dysphonia.
Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
[TBL] [Abstract][Full Text] [Related]
54. Liquid-type Botulinum Toxin Type A in Adductor Spasmodic Dysphonia: A Prospective Pilot Study.
Cha W; Jang JY; Wang SG; Kang JH; Jo MG
J Voice; 2017 May; 31(3):378.e19-378.e24. PubMed ID: 27520509
[TBL] [Abstract][Full Text] [Related]
55. Spasmodic dysphonia: new diagnosis and treatment opportunities.
Cook MJ; Lewin JS
Nurse Pract; 1994 Sep; 19(9):67-73. PubMed ID: 7816374
[TBL] [Abstract][Full Text] [Related]
56. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
Kosztyła-Hojna B; Berger G; Zdrojkowski M
Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
[TBL] [Abstract][Full Text] [Related]
57. Spasmodic dysphonia and laryngeal botulinum toxin injection.
Smith ME
West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914
[No Abstract] [Full Text] [Related]
58. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
Meyer TK; Hu A; Hillel AD
Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
[TBL] [Abstract][Full Text] [Related]
59. The effect of unilateral thalamic deep brain stimulation on the vocal dysfunction in a patient with spasmodic dysphonia: interrogating cerebellar and pallidal neural circuits.
Poologaindran A; Ivanishvili Z; Morrison MD; Rammage LA; Sandhu MK; Polyhronopoulos NE; Honey CR
J Neurosurg; 2018 Feb; 128(2):575-582. PubMed ID: 28304188
[TBL] [Abstract][Full Text] [Related]
60. Botulinum toxin as a therapeutic agent.
Tsui JK
Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
